Categories AlphaGraphs, Earnings, Health Care
AMGN Infographic: Amgen’s Q4 2022 profit drops on flat revenues
Amgen Inc. (NASDAQ: AMGN) said its revenues remained unchanged in the fourth quarter of 2022 when the biotechnology firm’s earnings declined.
Unadjusted earnings decreased to $4.09 per share in the December quarter from $4.40 per share in the year-ago period. The reported net income was $1.62 billion or $3.0 per share in the latest quarter, compared to $1.90 billion or $3.36 per share in the year-ago quarter.
Meanwhile, total revenues remained unchanged at $6.84 billion during the three-month period. A 4% increase in product sales was offset by weakness in the other business segments.
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
Key highlights from Johnson & Johnson’s (JNJ) Q2 2025 earnings results
Johnson & Johnson (NYSE: JNJ) reported its second quarter 2025 earnings results today. Reported sales increased 5.8% year-over-year to $23.7 billion. Operational sales growth was 4.6%. Net earnings grew over
Hasbro (HAS) Earnings Preview: What to expect from the Q2 2025 report
Shares of Hasbro, Inc. (NASDAQ: HAS) stayed red on Tuesday. The stock has gained 43% over the past three months. The toy company is scheduled to report its earnings results
Citigroup (C) Q2 FY25 earnings rise on higher revenues, beat estimates
Banking giant Citigroup Inc. (NYSE: C) reported higher revenues and earnings for the second quarter of fiscal 2025. The numbers also exceeded Wall Street's estimates. Net income increased to $4.0
